The reported incidence rate of primary congenital hypothyroidism (CH) has been increasing in the United States over the past 2 decades. We have considered the possibility that the inclusion of cases of transient hypothyroidism has inflated the reported incidence rate of CH. Assessing the effects of cases of transient hypothyroidism on the incidence rate is problematic, because the definitions, diagnostic criteria, and differentiation from transient hyperthyrotropinemia vary widely among state newborn screening programs. Among the 4 etiologies for transient hypothyroidism (maternal thyrotropin receptor-blocking antibodies, exposure to maternal antithyroid medications, iodine deficiency, and iodine excess), there is little evidence of increases in the incidence rate from thyrotropin receptor-blocking antibodies. Exposure to antithyroid drugs could contribute significantly to the incidence rate of transient CH, given the high estimated incidence of active maternal hyperthyroidism. Iodine deficiency or excess in the United States seems unlikely to have contributed significantly to the incidence rate of CH, because the secular trend toward lower iodine intake among women of reproductive age in the 1980s and 1990s seems to have plateaued, and perinatal iodine exposure has presumably declined as a result of recommendations to discontinue using iodinecontaining disinfectants. Although the female-to-male sex ratio among newborns with thyroid agenesis or dysgenesis (the most common causes of CH) is typically 2:1, analysis of the sex ratio of newborns diagnosed with presumed CH in the United States suggests that a substantial proportion might have transient hypothyroidism or hyperthyrotropinemia, because the sex ratio has been well below the expected 2:1 ratio. Combined ultrasonography and 123 I scintigraphy of the thyroid gland are effective tools for identifying cases of thyroid agenesis and dysgenesis and can help to differentiate cases of transient hypothyroidism from true CH. Imaging is also a vital component in evaluating children who, at 3 years of age, undergo a trial of discontinuation of levothyroxine treatment to test for persistence of hypothyroidism. Ultimately, thyroid gland imaging, in conjunction with longterm follow-up studies that appropriately assess and report whether there was permanence of hypothyroidism, will be necessary to address the true incidence rate of CH and any contribution to the observed rate by transient cases of hypothyroidism or hyperthyrotropinemia.
The purpose of this review was to consider whether the inclusion of newborns with transient forms of thyroid dysfunction have contributed to the reported increase in the incidence rate of primary congenital hypothyroidism (CH) in the United States. 1 For detailed discussions of the increasing incidence rate, see the articles by Olney et al 2 and Hinton et al. 3 We initially examined the various definitions of transient hypothyroidism used by different state newborn screening (NBS) programs. We reviewed the 4 recognized causes of transient hypothyroidism: exposure to maternal thyrotropin receptor-blocking antibodies (TRBAbs); exposure to antithyroid drugs; iodine deficiency; and iodine excess. We evaluated deviation from the expected 2:1 female-to-male sex ratio among newborns with reported CH as an indicator of potential misclassification of cases of transient hypothyroidism as permanent. We discussed ultrasound and radioisotope imaging of the thyroid gland as strategies for distinguishing between transient and permanent hypothyroidism. Finally, we reviewed the recommendations to reevaluate thyroid status and diagnosis among children with presumed CH after 3 years of treatment to determine if the hypothyroid state identified through NBS is permanent.
DEFINITIONS OF TRANSIENT HYPOTHYROIDISM
The definition of transient hypothyroidism in the medical literature is variable. According to a 2006 report of the American Academy of Pediatrics, which provided specific recommendations to guide the confirmatory process for newborns with a positive newborn screen result for hypothyroidism, the definition of transient hypothyroidism is abnormal screening values (low thyroxine [T4] and elevated thyrotropin [TSH] concentrations) resulting from one of the causes of transient hypothyroidism but normal serum T4 and TSH concentrations on a subsequent serum test at 1 to 2 months of age. 4 This definition implies that a definitive diagnosis of transient hypothyroidism can be achieved within the first 2 months of life, at which time the causes of transient hypothyroidism (see below) have generally resolved. Transient hypothyroidism should be distinguished from a falsepositive screening test, in which the latter is an abnormal screening-test result but a normal second-screen or serum-test result. In addition, falsepositive results have no identified cause for the initial positive screeningtest result, such as hypothyroxinemia of prematurity or one of the causes of transient hypothyroidism or transient hyperthyrotropinemia.
In contrast, although hyperthyrotropinemia (normal T4 and elevated TSH concentrations on confirmatory laboratory testing) also can be transient, this condition generally requires a longer time frame to distinguish between permanent and transient cases. There are heterogeneous etiologies for hyperthyrotropinemia, including delayed maturation of the hypothalamic-pituitary axis, increased TSH response to thyroidreleasing hormone, and presence of antithyroid antibodies, thyroid morphology abnormalities, or thyroperoxidase or thyrotropin receptor genesequence variations. 5, 6 Some of these etiologies overlap with the 4 recognized causes of transient hypothyroidism, whereas others account for permanent cases of hyperthyrotropinemia. Given the transient nature of many cases of hyperthyrotropinemia, there is controversy whether thyroid hormone therapy should be initiated. 7, 8 However, for those neonates started on treatment with levothyroxine, a trial off therapy at 3 years of age is recommended to distinguish those with transitory forms of hypothyroidism from those with true CH who require lifetime treatment. 4, 9 Authors of many surveillance or research studies do not distinguish between transient hypothyroidism and transient hyperthyrotropinemia and have defined all such cases as transient hypothyroidism. For example, in a study in Italy, researchers examined children with CH at 3 years of age and classified all who were no longer hypothyroid as having had transient hypothyroidism. 10 A study in Scotland distinguished cases of true CH from transient TSH elevation, which encompassed cases of both transient hypothyroidism and transient hyperthyrotropinemia. 11 Therefore, depending on the definition of transient hypothyroidism, there are likely to be significant differences between the reported incidence rates of this condition. Although the definition of transient hypothyroidism varies, the crucial reliable distinguishing factor between true CH and transitory forms of hypothyroidism is withdrawal of treatment after 3 years of age and assessment of thyroid function. Whether such examinations are conducted can result in significant differences in the reported incidence rate of CH.
There is little agreement among NBS programs in the United States on the definition of transient hypothyroidism. Current definitions are listed on the National Newborn Screening Information System (NNSIS) Web site. 12 All of them relate to dictionary definitions of "transient" as "remaining in place only a brief time" or "passing with time, ie, not permanent." These definitions provide wide latitude for interpretation and differ with respect to (1) whether an initial diagnosis of hypothyroidism is based on a screening test or a confirmatory serum test result, (2) whether both T4 and TSH concentrations must be abnormal, (3) the time allowed for concentrations to normalize on subsequent serum tests, and (4) 12 The female-to-male ratio was 0.7: 1.0 for transient hypothyroidism and 1.4:1.0 for CH. 12 Given the highly variable definitions from state to state, it is problematic to interpret accurately the incidence rate or geographical distribution of transient hypothyroidism on the basis of the NNSIS data.
CAUSES OF TRANSIENT HYPOTHYROIDISM
There are 4 recognized causes of transient hypothyroidism (Table 2) : transplacental passage of TRBAbs; transplacental passage of antithyroid drugs used to treat maternal hyperthyroidism; iodine deficiency; and iodine excess. Each can impair fetal production of thyroid hormone. Some forms of thyroid dyshormonogenesis caused by mutations in DUOXA2 or DUOX2 can cause transient hypothyroidism, 13 but these rare causes are not discussed here. It is interesting to note that the underlying etiology of transient hypothyroidism is not determined in many cases.
Thyrotropin Receptor-Blocking Antibodies
TRBAbs develop in the context of maternal autoimmune thyroid disease, such as Graves disease, chronic lymphocytic thyroiditis, and acquired hypothyroidism. They represent a subset of immunoglobulin G antibodies directed against the thyrotropin receptor on the plasma membrane of thyroid follicular cells. These antibodies cause hypothyroidism in the fetus and newborn by transplacental passage and blockage of the access of thyrotropin to fetal thyrotropin receptors. As with CH, serum T4 concentration is low and TSH concentration is high.
TRBAb testing should be considered for all newborns with a maternal history of hypothyroidism. Because of the blocking antibodies, the thyroid gland cannot be visualized by 123 I or 99 Tc scans, but the gland should be demonstrable in the normal anatomic location by ultrasonography.
Hypothyroidism caused by TRBAbs eventually resolves with the disappearance of maternal antibodies from the infant's circulation. The half-life of immunoglobulin G is on the order of 4 weeks, so thyroid hormone-replacement needs to be continued for 3 to 6 months.
Hypothyroidism caused by TRBAbs is uncommon and occurs in 1% to 2% of all newborns with hypothyroidism or 1 in 180 000 live births. 5 There is no evidence that this form of transient hypothyroidism has made a major contribution to the observed increase in the reported incidence rate of CH.
Antithyroid Drugs and Treatment of Maternal Hyperthyroidism
Propylthiouracil and methimazole, both used in the management of maternal hyperthyroidism, cross the placenta and inhibit fetal thyroid hormone production. The objective of medical management of Graves disease during pregnancy is to maintain maternal T4 concentrations in the upper part of the normal range for each stage of gestation. Newborns who are known to be at risk for hypothyroidism because of maternal antithyroid-drug exposure should have serial measurements of T4 and TSH over the first week or two of life, with the expectation that drug effects causing low T4 and elevated TSH concentrations will resolve within this interval.
The frequency of active maternal hyperthyroidism has been estimated to be from 1 in 1000 to 1 in 200. 14 This is much higher than the overall reported frequency of transient hypothyroidism. It is possible that many cases of transient hypothyroidism caused by maternal use of antithyroid drugs have not been reported to state NBS programs.
Iodine Deficiency
Iodine is an absolute requirement for maternal, fetal, and postnatal thyroid hormone synthesis. Newborns affected with iodine deficiency have low T4 and high TSH concentrations. With radioisotope imaging, there is avid uptake of 123 I by a normally located gland. Treatment involves iodine replacement until normal iodine balance is achieved.
On a global basis, iodine deficiency is the most common cause of transient hypothyroidism, particularly in preterm newborns. [15] [16] [17] Preterm newborns are at higher risk because they have been prematurely deprived of the maternal supply of thyroid hormone, as well as iodine, which leads to inadequate accumulation of iodine in the thyroid gland compared with that of term newborns. Hypothyroidism represents a form of the broader category of iodine-deficiency disorders, which include endemic goiter, hypothyroidism, cretinism, decreased fertility rate, increased infant mortality, and intellectual disability. 18 There is extreme variation in iodine deficiency among countries and among regions within the same country. For example, in central Africa, where iodine deficiency exists in tandem with a dietary excess of thiocyanate, which inhibits transport of iodide into the thyroid gland, a study showed that up to 10% of newborns had cord blood T4 concentrations of Ͻ3 g/dL and TSH concentrations of Ͼ100 mU/L. 19 Results of an Italian study indicated that the overall incidence rate of CH detected by screening was 1 in 3200, but in several districts historically affected by iodine deficiency there was an incidence rate of Ͼ1 in 2000; more than half (58%) of the case newborns in these districts had normally located thyroid glands and transient hypothyroidism. 20 A report from Krakow, Poland, showed the importance of public health policies for preventing transient hypothyroidism. 21 The incidence rate of transient hypothyroidism was 1 in 3920 from 1985 through 1991, but it declined in the community to 1 in 48 474 from 1992 through 2000, during which time iodized salt was reintroduced.
Commonly used measures of iodine insufficiency include urinary iodine (UI) concentration and the proportion of NBS specimens with a TSH concentration of Ͼ5 mU/L. 22 The World Health Organization criterion for assessing the iodine nutrition status of a population SUPPLEMENT ARTICLE using casual urine specimens is based on the median UI concentration. 22 For a population of pregnant women, a median UI concentration of Ͻ150 g/L is considered indicative of iodine deficiency, and a median UI concentration of 150 to 249 g/L is considered adequate; for nonpregnant women, the values are Ͻ100 and 100 to 199 g/L, respectively.
In Dried-blood-spot TSH concentrations are often used as an indirect measure of iodine deficiency at the population level, 26 but this process requires that specimens be collected at least 72 hours after birth, because TSH concentrations values first surge and then decrease rapidly during the first several postnatal days. 27 Consequently, the percentage of neonatal thyrotropin concentrations of Ͼ5 mU/L in newborn specimens collected by US NBS programs cannot be used for this purpose. Umbilical cord blood specimens have also been used to assess iodine deficiency at the population level, although such specimens are not routinely collected and may not be an appropriate indicator of iodine deficiency in the United States. In 1 study, a high prevalence of elevated TSH concentrations was found at study sites in Bangladesh, Guatemala, and Atlanta, Georgia; values were Ͼ5 mU/L in 84%, 58%, and 82% of neonatal cord blood specimens, respectively, which suggests severe iodine deficiency at all sites. 28 The median UI values among pregnant women at each of the sites were 96, 120, and 105 g/L, respectively, which indicates that the pregnant women at all 3 study sites had insufficient iodine intakes on average. However, the authors suggested that the elevated newborn TSH concentrations in the US samples might have been due, in part, to ␤-iodine antiseptic exposure among 98% of the mothers for intravenous access, bladder catheterization, or epidural anesthesia (see "Iodine Excess") rather than true chronic maternal iodine deficiency.
Although maternal iodine deficiency certainly exists in the United States, its prevalence does not seem to have increased over the past 2 decades, so it is unlikely that transient hypothyroidism caused by iodine deficiency has contributed significantly to the observed increase in the reported incidence rate of CH. However, certain elements of the population might be at higher risk, particularly when borderline iodine nutrition is combined with exposure to goitrogens (inhibitors of thyroid gland function that interfere with iodine uptake) such as perchlorate and organochlorines, so assessing for transient hypothyroidism among offspring of this group of women definitely bears further study.
Iodine Excess
The Wolff-Chaikoff effect involves transient inhibition of T4 synthesis by excessive plasma concentrations of inorganic iodine. The effect lasts for ϳ10 days and is followed by an escape from suppression with resumption of normal iodine organification and normal thyroid peroxidase function. Iodine excess can be associated with the use of iodine-containing antiseptics, contrast agents, and certain drugs (including amiodarone) and ingestion of seaweed. Iodine passes freely from the maternal to the fetal circulation system and also can be transmitted through breast milk. Because most newborn exposure to iodine occurs during labor and delivery or postnatally, elevated TSH concentrations might not be evident in specimens taken on the first or second day after birth. The newborn with transient hypothyroidism caused by excessive iodine exposure will have low T4 and high TSH concentrations, generally after 2 to 3 days of age, as in other forms of hypothyroidism. 123 I imaging will fail to show a thyroid gland, because excess iodine blocks 123 I uptake, although ultrasonography will show a gland in the normal location that might or might not be enlarged.
Results of several studies have indicated that transient hypothyroidism is more common among newborns in hospitals that use iodine for skin disinfection than in those that use chlorhexidine. [29] [30] [31] The incidence rate of transient hypothyroidism was especially high in a Berlin, Germany, hospital that used povidone-iodine for cleansing of the umbilical stump. 31 In contrast, a prospective controlled study from a NICU in Massachusetts did not demonstrate a difference in mean T4 or TSH concentrations between newborns who had routine skin cleansing with povidone-iodine versus those for whom chlorhexidine was used. 32 However, topical iodine exposure during the birthing process cannot be excluded as a cause of transient hypothyroidism in the United States, because preterm newborns and those born in iodine-deficient regions (who, among the latter, already have low T4 and high TSH concentrations resulting from iodine deficiency) might be more susceptible to the Wolff-Chaikoff effect of topical iodine exposure.
Iodine-containing radiologic contrast agents are also a source of free iodine. A study from Germany revealed that such contrast agents can compromise thyroid function among preterm newborns. 33 However, the authors also reported that the use of either of 2 contrast agents was not as disruptive to thyroid function among preterm newborns as the use of an iodinecontaining antiseptic for long-term skin care.
Dietary iodine excess is a major issue in Japan because of ingestion of kombu, a type of seaweed, as a vegetable and incorporated in soups and food additives. In 1 study, nearly half of the newborns recalled for thyroid evaluation after screening had a history of excessive maternal iodine ingestion of 2300 to 3200 g/day. 34 Levothyroxine replacement was used among 75% of the newborns because of persistent elevations of TSH concentration, which the authors hypothesized was a result of consumption of iodine by the infants and susceptibility to the inhibitory effect of iodine. Treatment was generally continued until 2 years of age.
Treatment with the antiarrhythmic drug amiodarone can alter thyroid function. 35 The drug is used among pregnant women and among newborns with congenital heart disease. It contains 37% iodine by weight, and its structure resembles T4. It can cause either hypothyroidism or hyperthyroidism through interaction with the thyroid hormone receptor. These effects can persist for many months after exposure.
Numerous studies that have evaluated the effects of topical iodine exposure on preterm newborns have each recommended that routine use of iodine-containing antiseptics be avoided in this population. 31, 33, [36] [37] [38] Therefore, it is reasonable to assume that the use of these products in NICUs has declined, so it seems unlikely that iodine excess can account for the reported increase in the incidence rate of CH in the United States. Nevertheless, questioning about iodine exposure continues to be an important part of the medical history for newborns with positive screen results for hypothyroidism, and iodine excess from procedurerelated exposure should be suspected when newborns from a particular hospital have a high rate of elevated TSH concentrations.
SEX RATIOS AND TRANSIENT HYPOTHYROIDISM
The reported (from studies of European, Australian, and Canadian newborns 10, 11, [39] [40] [41] ) female-to-male sex ratio among case infants with true CH is ϳ2:1. The ratio was even higher (2.4: 1.0) among newborns with CH caused specifically by thyroid aplasia or ectopy. 39 According to results from studies in Italy, the female-to-male ratio was 2:1 among newborns with thyroid dysgenesis, which accounted for ϳ75% of all newborns with CH; 1:1 among newborns with CH with eutopic (normally positioned and normalappearing) glands; and 0.5:1.0 among newborns with transient hypothyroidism. 10, 42 In a Scottish study, the femaleto-male sex ratio was 2.2:1.0 among 224 newborns with definite CH and 1:1 among 88 newborns with transient hypothyroidism. 40 In the United States there have been no systematic longterm follow-up studies to evaluate the sex ratio among newborns with transient versus permanent hypothyroidism. However, the sex ratio among newborns with CH seems to vary significantly according to race or ethnicity (see the article by Hinton et al 3 ), so deviations from the expected 2:1 ratio might be expected in the United States in contrast to that in the more homogeneous populations in Europe, Australia, and Canada.
We conducted a study of the sex ratios among neonates with presumed CH in the United States by using NBS data for the period 1993-2000, obtained from the National Newborn Screening and Genetics Resource Center and previously validated by the reporting programs. For newborn boys or girls, the odds of being diagnosed with CH were estimated by using a negative binomial distribution to account for extraPoisson variation using SAS 9.2 (SAS Institute, Inc, Cary, NC). For all states combined, the odds ratio for case infants was determined to be 1.56:1.00 (female-to-male). An analysis according to state showed that the sex ratio was not uniform among state NBS programs. The majority of states had a sex ratio of Ͻ1.9:1.0, although 13 states had sex ratios of Ն1.9:1.0. The most recent NNSIS data in 2008 showed a female-to-male ratio in the United States of 1.4:1.0 for newborns with presumed CH, which is still substantially lower than the expected 2:1 ratio. This observed sex ratio was inconsistent with the experience of NBS programs in other countries, which consistently reported 2 or more girls for each boy diagnosed with true CH. This observation raises the possibility that a significant proportion of newborns in the United States reported to have CH after NBS and confirmatory testing do not, in fact, have true CH but could have transient hypothyroidism or transient hyperthyrotropinemia, which has a much lower female-tomale ratio of ϳ1:1. Additional studies will be necessary to evaluate this hypothesis. One recent study evaluated a standardized protocol to assess the permanence of presumed CH at a pediatric endocrinology clinic in Indiana. 9 Children with presumed CH who were eligible for the study were those with an anatomically normal thyroid gland on imaging; those without previous diagnostic imaging; or those who did not have imaging but had relatively mild abnormalities in T4 and TSH concentrations despite apparent thyroid agenesis on technetium scans. There was no mention of whether absence of TSH elevation during treatment was a criterion for the study. T4 treatment was discontinued for 4 weeks before having thyroid-function tests and a thyroid ultrasound. Those with an abnormal thyroid ultrasound result underwent a technetium scan. Children with a normal thyroid ultrasound result but abnormal thyroid-function tests had a perchlorate-discharge test. Children with normal results had repeat thyroid-function tests 4 and 6 months later. Of the 33 children in the study, 27% had dysgenesis or agenesis of the thyroid gland, 36% had a defect in the iodination of tyrosine residues on thyroglobulin (organification defect) or other forms of dyshormonogenesis, and 36% were euthyroid and remained euthyroid at 4 and 6 months. Thus, more than one-third of the eligible children for the study were found to have had a transient form of hypothyroidism, although the majority had hyperthyrotropinemia on confirmatory testing for the abnormal NBS test result. These results provide a rational and effective protocol for establishing the definitive diagnosis and the permanence of hypothyroidism. However, although comprehensive, this approach is not the only one. A study in Toronto, Ontario, Canada, 2 decades earlier concluded that after 3 years of age, a 3-week withdrawal of thyroid hormone alone was sufficient for adequate and safe confirmation of permanent hypothyroidism. 46 In contrast, a report from China suggested that a longer period of withdrawal from thyroid hormone is necessary for a definitive diagnosis. 47 Among 1144 children with presumed CH, 157 required only a low maintenance dose of levothyroxine to maintain normal T4 and TSH concentrations. These 157 children underwent withdrawal of treatment at 2 to 3 years of age; 90% eventually achieved normal TSH concentrations, although the TSH concentration remained elevated in 25% of them at 1 month, 4% at 2 months, and Ͻ1% at 10 months after discontinuing treatment. The remaining 15 children (10%) had high concentrations of TSH while off treatment and were restarted on levothyroxine. The authors concluded that the optimal observation period for determining if thyroid function is normal while off treatment is 2 to 3 months. The fact that one-quarter of the children had persistent TSH elevations even after 1 month off treatment might have reflected an elevated proportion of children in China with iodine deficiency and a prolonged period of recovery of normal thyroid function. The shorter withdrawal time of 1 month generally is regarded as appropriate for use in the United States; however, in the absence of a comparable large-scale study in the United States, it is not certain.
THYROID IMAGING AND TRANSIENT HYPOTHYROIDISM

CONCLUSIONS
Transient hypothyroidism certainly exists in the United States, although a precise definition for the condition is lacking, and there is great variability among state NBS programs as to which newborns are classified with this condition, as well as the reported incidence rate of transient hypothyroidism. Some confusion arises regarding the differentiation of transient hypothyroidism from transient hyperthyrotropinemia, which might represent a continuum along a scale of thyroid dysfunction. It seems likely that the 4 etiologies of transient hypothyroidism (TRBAbs, antithyroid drugs, iodine deficiency, and iodine excess) have not had substantial changes in prevalence over time and, therefore, have not contributed significantly to the increasing incidence rate of CH in the United States. However, it is important to consider these etiologies in every case of neonatal hypothyroidism because newborns who had both maternal and fetal thyroid hormone concentrations compromised, as can be the case with TRBAbs or iodine deficiency, will have significant future risk of mental impairment despite early diagnosis and management of transient hypothyroidism. It is clear that newborns diagnosed with presumedpermanent CH in the United States do not follow the expected 2:1 female-tomale sex ratio, which indicates a high likelihood that newborns with transient hypothyroidism or hyperthyrotropinemia are being misclassified as having true CH, thus perturbing the ratio. It seems that the use of thyroid gland imaging, in conjunction with long-term follow-up studies that appropriately assess and report whether there is permanence of hypothyroidism, will be necessary to determine the true incidence rate of CH and any contribution of transient hypothyroidism to the reported increasing incidence rate of CH.
